东京热福利视频导航|日韩无码不卡一区|成人高清手机在线|在厨房乱子伦对白一区二区|中文字幕网址导航|国产原创在线亚洲黄色大片高清无码|深爱激情五月丁香亚洲综合社区|成人在线手机视频|浮力影院成人A片|日韩限制电影在线观看

Therapeutic Advances In Cardiovascular Disease
收藏雜志
  • 數(shù)據(jù)庫(kù)收錄SCIE
  • 年發(fā)文量16

Therapeutic Advances In Cardiovascular Disease

期刊中文名:心血管疾病治療進(jìn)展ISSN:1753-9447E-ISSN:1753-9455

該雜志國(guó)際簡(jiǎn)稱(chēng):THER ADV CARDIO DIS,是由出版商SAGE Publishing出版的一本致力于發(fā)布--研究新成果的的專(zhuān)業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專(zhuān)論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。

基本信息:
期刊簡(jiǎn)稱(chēng):THER ADV CARDIO DIS
是否OA:開(kāi)放
是否預(yù)警:
Gold OA文章占比:94.74%
出版信息:
出版地區(qū):United Kingdom
出版語(yǔ)言:English
出版商:SAGE Publishing
評(píng)價(jià)信息:
JCR分區(qū):Q2
影響因子:2.6
CiteScore:3.5
雜志介紹 JCR分區(qū) CiteScore 投稿經(jīng)驗(yàn)

雜志介紹

Therapeutic Advances In Cardiovascular Disease雜志介紹

《Therapeutic Advances In Cardiovascular Disease》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊,中文名稱(chēng)心血管疾病治療進(jìn)展,本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.6,最新CiteScore 指數(shù)為3.5。

英文介紹

Therapeutic Advances In Cardiovascular Disease雜志英文介紹

Therapeutic Advances in Cardiovascular Disease is an international peer-reviewed journal focused on the treatment of cardiovascular diseases. This journal is dedicated to publishing innovative research in the treatment of heart and circulatory system diseases, including original research articles, reviews, and academic reviews. It focuses on clinical and pharmacological aspects and is aimed at clinical doctors and researchers in cardiology, circulatory system diseases, and related disciplines worldwide, with the aim of rapidly disseminating the latest research and perspectives in this field.

The magazine editorial team is composed of experts from around the world who conduct rigorous peer review of manuscripts to ensure that the published content has high quality and academic value. The magazine not only focuses on basic research, but also emphasizes the exploration of clinical practice and treatment strategies, providing readers with in-depth academic discussions and practical guidance. It is an academic journal dedicated to the research of cardiovascular disease treatment, providing a platform for researchers worldwide to showcase and exchange research results, especially in understanding the treatment strategies and clinical applications of cardiovascular disease, which has important academic value and practical significance.

JCR分區(qū)(2023-2024年最新版)

Therapeutic Advances In Cardiovascular Disease雜志 JCR分區(qū)信息

按JIF指標(biāo)學(xué)科分區(qū)
學(xué)科:CARDIAC & CARDIOVASCULAR SYSTEMS
收錄子集:ESCI
分區(qū):Q2
排名:84 / 220
百分位:

62%

按JCI指標(biāo)學(xué)科分區(qū)
學(xué)科:CARDIAC & CARDIOVASCULAR SYSTEMS
收錄子集:ESCI
分區(qū):Q3
排名:128 / 220
百分位:

42.05%

JCR分區(qū):JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類(lèi)按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。

CiteScore 評(píng)價(jià)數(shù)據(jù)(2024年最新版)

Therapeutic Advances In Cardiovascular Disease雜志CiteScore 評(píng)價(jià)數(shù)據(jù)

  • CiteScore 值:3.5
  • SJR:0.553
  • SNIP:0.779
學(xué)科類(lèi)別 分區(qū) 排名 百分位
大類(lèi):Medicine 小類(lèi):Cardiology and Cardiovascular Medicine Q2 177 / 387

54%

大類(lèi):Medicine 小類(lèi):Pharmacology (medical) Q3 148 / 272

45%

歷年影響因子和期刊自引率

投稿經(jīng)驗(yàn)

Therapeutic Advances In Cardiovascular Disease雜志投稿經(jīng)驗(yàn)

該雜志是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,該雜志在綜合專(zhuān)業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國(guó)際優(yōu)秀雜志,一般投稿過(guò)審時(shí)間都較長(zhǎng),投稿過(guò)審時(shí)間平均 9 Weeks ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請(qǐng)咨詢(xún)客服。

免責(zé)聲明

若用戶(hù)需要出版服務(wù),請(qǐng)聯(lián)系出版商。